Trial Outcomes & Findings for Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy (NCT NCT02690168)

NCT ID: NCT02690168

Last Updated: 2021-07-19

Results Overview

Recruitment status

COMPLETED

Target enrollment

6 participants

Primary outcome timeframe

80 hours

Results posted on

2021-07-19

Participant Flow

Participant milestones

Participant milestones
Measure
Fasting
72 hour fasting
Overall Study
STARTED
6
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Collected data from one participant were not considered valid due to an equipment malfunction

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Healthy Men
n=6 Participants
Fasting: 72 hour fasting
Age, Continuous
28.7 years
STANDARD_DEVIATION 2.4 • n=6 Participants
Sex: Female, Male
Female
0 Participants
n=6 Participants
Sex: Female, Male
Male
6 Participants
n=6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=6 Participants
Race (NIH/OMB)
Asian
0 Participants
n=6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=6 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=6 Participants
Race (NIH/OMB)
White
3 Participants
n=6 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=6 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=6 Participants
Weight
76.1 kg
STANDARD_DEVIATION 13.7 • n=6 Participants
Body Mass Index
23.5 kg/m^2
STANDARD_DEVIATION 2.7 • n=6 Participants
Fasting glucose
85.1 mg/dL
STANDARD_DEVIATION 6.9 • n=6 Participants
% body fat
17.6 % body fat
STANDARD_DEVIATION 7.3 • n=6 Participants
Percent enrichment of bicarbonate
53.5 % enrichment
STANDARD_DEVIATION 8.3 • n=5 Participants • Collected data from one participant were not considered valid due to an equipment malfunction
Cerebral Metabolic Rate of Acetate Ascertained Through Mathematical Modeling of MRS Data
59 micromol/g/min
STANDARD_DEVIATION 20.8 • n=5 Participants • Collected data from one participant were not considered valid due to an equipment malfunction
Astroglial tricarboxylic acid cycle rate ascertained through mathematical modeling of MRS data
0.5 micromol/g/min
STANDARD_DEVIATION 0.2 • n=5 Participants • Collected data from one participant were not considered valid due to an equipment malfunction
Leptin
7.2 ng/mL
STANDARD_DEVIATION 5.9 • n=3 Participants • parameter could only be measured in 3 subject due to lack of collected blood volume

PRIMARY outcome

Timeframe: 80 hours

Population: Collected data from one participant were not considered valid due to an equipment malfunction

Outcome measures

Outcome measures
Measure
Healthy Men
n=5 Participants
Fasting: 72 hour fasting
Percent Enrichment of Bicarbonate as Measured by Magnetic Resonance Spectroscopy (MRS)
61.9 % enrichment
Standard Deviation 3.8

SECONDARY outcome

Timeframe: 80 hours

Population: Collected data from one participant were not considered valid due to an equipment malfunction

Outcome measures

Outcome measures
Measure
Healthy Men
n=5 Participants
Fasting: 72 hour fasting
Cerebral Metabolic Rate of Acetate Ascertained Through Mathematical Modeling of MRS Data
71 micromol/g/min
Standard Deviation 15.0

SECONDARY outcome

Timeframe: 80 hours

Population: Collected data from one participant were not considered valid due to an equipment malfunction

Outcome measures

Outcome measures
Measure
Healthy Men
n=5 Participants
Fasting: 72 hour fasting
Astroglial TCA Cycle Rate Ascertained Through Mathematical Modeling of MRS Data
0.4 micromol/g/min
Standard Deviation 0.2

SECONDARY outcome

Timeframe: 72 hours

Outcome measures

Outcome measures
Measure
Healthy Men
n=6 Participants
Fasting: 72 hour fasting
Glucose Level
71 mg/dL
Standard Deviation 4.9

SECONDARY outcome

Timeframe: 72 hours

Population: Data from 3 participants was not available due to lack of blood volume during collections

Outcome measures

Outcome measures
Measure
Healthy Men
n=3 Participants
Fasting: 72 hour fasting
Change in Leptin Levels
5.2 ng/mL
Standard Deviation 1.2

Adverse Events

Fasting

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Fasting
n=6 participants at risk
72 hour fasting
Musculoskeletal and connective tissue disorders
Achy legs
16.7%
1/6 • Number of events 1 • 4 days
Gastrointestinal disorders
vomiting
16.7%
1/6 • Number of events 1 • 4 days
Nervous system disorders
Headache
50.0%
3/6 • Number of events 3 • 4 days
Respiratory, thoracic and mediastinal disorders
sinus congestion
16.7%
1/6 • Number of events 1 • 4 days
Nervous system disorders
insomnia
16.7%
1/6 • Number of events 1 • 4 days

Additional Information

Dr. David McDougal

Pennington Biomedical Research Center

Phone: 2257630278

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place